(Q41228940)

28 September 2017

1 reference

title

Etoposide phosphate, the water soluble prodrug of etoposide (English)

1 reference

28 September 2017

1 reference

3

J H Beijnen

1 reference

28 September 2017

A H Witterland

1

1 reference

PubMed ID

8933576

28 September 2017

C H Koks

series ordinal

2

1 reference

PubMed ID

8933576

28 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

International Journal of Clinical Pharmacy

28 September 2017

1 reference

28 September 2017

18

1 reference

28 September 2017

5

1 reference

28 September 2017

163-170

1 reference

A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity

28 September 2017

1 reference

12 December 2020

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate

1 reference

12 December 2020

The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of oral etoposide phosphate

1 reference

12 December 2020

Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors

1 reference

12 December 2020

Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids

1 reference

12 December 2020

Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer

1 reference

12 December 2020

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

12 December 2020

The human alkaline phosphatases: what we know and what we don't know

1 reference

12 December 2020

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer

1 reference

12 December 2020

Future directions for etoposide therapy

1 reference

12 December 2020

Hypersensitivity reactions to etoposide

1 reference

12 December 2020

Clinical and pharmacokinetic overview of parenteral etoposide phosphate

1 reference

12 December 2020

Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30

1 reference

12 December 2020

Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial

1 reference

12 December 2020

Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia

1 reference

12 December 2020

Abnormal alkaline phosphatase of hepatic type in cerebrospinal fluid of a patient with intracranial metastasis from lung cancer

1 reference

12 December 2020

Pharmacokinetics of high-dose etoposide after short-term infusion

1 reference

12 December 2020

Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors

1 reference

12 December 2020

Cracking of ABS plastic devices used to infuse undiluted etoposide injection

1 reference

12 December 2020

Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.

1 reference

12 December 2020

A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days

1 reference

12 December 2020

Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease

1 reference

12 December 2020

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration

1 reference

12 December 2020

Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic data

1 reference

12 December 2020

Penetration of etoposide into human malignant brain tumors after intravenous and oral administration

1 reference

12 December 2020

Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of a 14-day infusion of etoposide in patients with lung cancer

1 reference

12 December 2020

Etoposide (VP-16-213). Current status of an active anticancer drug

1 reference

12 December 2020

The chemical and biological route from podophyllotoxin glucoside to etoposide: ninth Cain memorial Award lecture

1 reference

12 December 2020

Bioavailability of low-dose oral etoposide

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00820727

1 reference

28 September 2017

1 reference

PubMed ID

8933576